At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
da vinc SP gastrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using da Vinci SP for Early Gastric Cancer
In Brief
A clinical study evaluating da vinc SP gastrectomy for Gastric Cancer. Completed, enrolled 19 participants across 1 site.
Detailed Summary
Laparoscopic surgery revolutionized the surgical treatment of gastric cancer saving large incsion and associated pain. Robotic surgical system was introduced to enhance the minimally invasive surgery using articulating robotic arm. The da vinci SP system, which enables single-port surgery, can allow surgeon to provide radical gastrectomy with minimal scar and associated pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedSep 2021
Enrollment StartDec 2021
Primary CompletionNov 2022
Study CompletionDec 2022
TodayJul 2026
First PostedSep 21, 2021
Enrollment StartDec 16, 2021
Primary CompletionNov 11, 2022
Study CompletionDec 11, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.8 years ago
Interventions
da vinc SP gastrectomyprocedure
radical subtotal gastrectomy performed by da vinci SP